MedTrace Logo

Multiple Myeloma Prognostic Indices

NCT06095752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2025-10-02

No results posted yet for this study

Summary

The aim of this study was to evaluate the impact of albumin / fibrinogen ratio, blood viscosity and RDW on the prognosis of a newly diagnosed MM patients

Conditions

Interventions

OTHER

blood viscosity , albumin / fibrinogen ratio and red cell distribution

In multiple myeloma patients ,we get blood viscosity , albumin / fibrinogen ratio and red cell distribution directly after confirmed diagnosis to determine the prognosis of the disease in association with these tests results

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06095752 on ClinicalTrials.gov